Meuer S C, Hussey R E, Cantrell D A, Hodgdon J C, Schlossman S F, Smith K A, Reinherz E L
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1509-13. doi: 10.1073/pnas.81.5.1509.
Human T-cell clones and anti-T-cell-receptor antibodies (clonotypic) directed at surface receptors for antigen (T3-Ti molecular complex) as well as anti-interleukin 2 (IL-2) and anti-IL-2-receptor antibodies were utilized to investigate the mechanism by which alloantigens or antigen plus self-major histocompatibility complex (MHC) (i.e., physiologic ligand) trigger specific clonal proliferation. Soluble or Sepharose-bound anti-Ti monoclonal antibodies, like physiologic ligand, enhanced proliferative responses to purified IL-2 by inducing a 6-fold increase in surface IL-2 receptor expression. In contrast, only Sepharose-bound anti-Ti or physiologic ligand triggered endogenous clonal IL-2 production and resulted in subsequent proliferation. The latter was blocked by antibodies directed at either the IL-2 receptor or IL-2 itself. These results suggest that induction of IL-2 receptor expression but not IL-2 release occurs in the absence of T3-Ti receptor cross-linking. Perhaps more importantly, the findings demonstrate that antigen-induced proliferation is mediated through an autocrine pathway involving endogenous IL-2 production, release, and subsequent binding to IL-2 receptors.
利用人T细胞克隆以及针对抗原表面受体(T3-Ti分子复合物)的抗T细胞受体抗体(克隆型),还有抗白细胞介素2(IL-2)和抗IL-2受体抗体,来研究同种异体抗原或抗原加自身主要组织相容性复合体(MHC)(即生理性配体)触发特异性克隆增殖的机制。可溶性或结合琼脂糖的抗Ti单克隆抗体,如同生理性配体一样,通过使表面IL-2受体表达增加6倍,增强了对纯化IL-2的增殖反应。相反,只有结合琼脂糖的抗Ti或生理性配体触发内源性克隆IL-2的产生,并导致随后的增殖。后者被针对IL-2受体或IL-2自身的抗体所阻断。这些结果表明,在没有T3-Ti受体交联的情况下会发生IL-2受体表达的诱导,但不会发生IL-2释放。也许更重要的是,这些发现表明抗原诱导的增殖是通过一种自分泌途径介导的,该途径涉及内源性IL-2的产生、释放以及随后与IL-2受体的结合。